Laser treatment in urology: our experience with neodymium:YAG and carbon dioxide lasers.
Laser surgery is currently considered as an effective alternative in the treatment of several urological diseases. We report on our three-year experience treating recurrent superficial low grade bladder carcinoma in 80 patients using Neodymium: YAG (Nd:YAG) laser. A decrease in local tumour recurrence rate (11%) was observed, but the overall not treated area recurrence was 45%. No complications were noted when the procedure was carried out on outpatient basis. Furthermore, we have been treating successfully urogenital condylomata using Nd:YAG and carbon dioxide (CO2) lasers in 364 patients. In addition we describe the use of Nd:YAG laser in the percutaneous treatment of a patient with bilateral transitional cell carcinoma of the renal pelvis.
Sakkas
G
G
Department of Urology, University of Athens Medical School, Greece.
Karagiannis
A
A
Karayannis
D
D
Dimopoulos
K
K
D000328:Adult; D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000601:surgery*; D003218:Condylomata Acuminata / Q000601:surgery; D005260:Female; D052776:Female Urogenital Diseases / Q000601:surgery; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery; D017075:Laser Coagulation; D008297:Male; D052801:Male Urogenital Diseases; D008875:Middle Aged; D009354:Neodymium; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D001749:Urinary Bladder Neoplasms / Q000601:surgery*; D015019:Yttrium
D009354:Neodymium; D015019:Yttrium